NASDAQ NMS - GLOBAL MARKET · CYPH
+36.13% · +$0.4300 · Vol 19.0M
Market closed · last close 4:00 PM ET · price as of 19:59:55 ET
Cypherpunk Technologies Inc

Cypherpunk Technologies Inc

Biotechnology
$1.62
Card
Relationship Map

Veridion Score

BETALOW CONF · 4/6 factorsMethodology
Earnings absence reason unknown · Sentiment absence reason unknown
CYPH
Cypherpunk Technologies Inc
Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
BUY BIAS

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

65/ 100
Veridion Score
BUY BIAS · LOW confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 4/6 factors with data · Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is CYPH moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading CYPH catalysts
About Cypherpunk Technologies Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2014
Employees
6
Country
US

Cypherpunk Technologies Inc is a privacy technology company focused on implementing a digital asset treasury business anchored by Zcash, which is a cryptographic digital asset that operates on a decentralized, open-source blockchain network known as the Zcash Network. Through its subsidiary, the company is also engaged in developing novel therapies for patients with cancer. The group holds Zcash as part of its digital treasury business and has the following drug candidates under development in its biopharma business: Sirexatamab (DKN-01), a monoclonal antibody that inhibits Dickkopf-related protein 1, or DKK1; and a preclinical antibody program, FL-501, that is designed to treat cachexia-related indications.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$1.32
Day high
$1.45
Day low
$1.19
Previous close
$1.19
52W high
$2.97
-45.45% from high
52W low
$0.5135
45% of range
Market cap
$153M
EPS
$-0.5600
Beta
6.02
Shares out
107.8M
Volume
19M
7.35× rel vol
Avg volume
2.6M
VWAP
$1.43
Price history computed in-house
1W
+129.69%
1M
+160.66%
3M
+39.66%
YTD
+39.66%
SMA 50 $0.7125 · above
SMA 200 Not reported · Not reported
52W position 45%

CYPH overview

Veridion Score
65
Registered · 2026-08-21
4 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around CYPH.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading CYPH Form 4 filings
Public disclosures

Congress activity in CYPH

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for CYPH in the cached public ledger.

Federal contracts

CYPH contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for CYPH in this window.
Lobbying spend

CYPH lobbying filings, year to date.

Registered lobbying filings matched to Cypherpunk Technologies Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for CYPH in this window.
Loading news for CYPH
Analyst ratings
Sovereign unlock shows live analyst consensus for CYPH.
Options
Sovereign unlock shows live options positioning for CYPH.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.